PEMF in the Treatment of Fresh Distal Radius Fractures
Launched by TEL-AVIV SOURASKY MEDICAL CENTER · Feb 26, 2020
Trial Information
Current as of April 24, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects with closed unilateral dorsally angulated fracture of the distal radius (Colles') visible by x-ray.
- • 2. Subjects treated conservatively by immobilization ± closed reduction
- • 3. Age \>18 years
- • 4. Subjects able to adhere to the visit schedule and protocol requirements and be available to complete the study.
- Exclusion Criteria:
- • 1. Subjects with intra articular fracture or extra-articular fracture that meets the criteria for operative fracture fixation.
- • 2. Subjects with pins or plates in the wrist
- • 3. Sustained previous fractures or bone surgery in the currently fractured distal forearm
- • 4. Synovial pseudarthrosis
- • 5. Subjects with multiple trauma (several fractures at once)
- • 6. Subjects suffering from joint diseases that affect the function of the wrist and/or hand of the injured arm.
- • 7. Pregnancy
- • 8. Women who are breast-feeding.
- • 9. Women of childbearing potential and not using a medically accepted form of contraception when sexually active.
- • 10. presence of a life supporting implanted electronical device
About Tel Aviv Sourasky Medical Center
Tel Aviv Sourasky Medical Center, a leading academic medical institution in Israel, is renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a multidisciplinary approach, the center integrates cutting-edge medical technology and evidence-based practices to enhance patient care and outcomes. Its robust infrastructure supports a diverse range of clinical studies, fostering collaboration among healthcare professionals, researchers, and industry partners. The center's dedication to research excellence and patient safety positions it as a key player in the global clinical research landscape, driving advancements in medical knowledge and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials